← SynDRA
FIDRISERTIB
SynDRA canonical compound SYN0040249 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Primary target(s) | ALK |
|---|
| Mechanism of action | alk inihibitor |
|---|
| Indication | glioma |
|---|
| Disease area | oncology |
|---|
All known targets
Mechanisms of action (all sources)
- ACVR1 INHIBITOR
- alk inihibitor
Cross-references
Synonyms
- BLU-782
- IPN60130
- ALK2-IN-1
- IPN-60130
- BLU782
- KF4ZI0CJ7M
- FIDRISERTIB [INN]
- RefChem:140418
- UNII-KF4ZI0CJ7M
- Fidrisertib (USAN/INN)
- FIDRISERTIB [USAN]
- orb1299212
- SCHEMBL19482404
- SCHEMBL29780363
- GTPL11875
- GLXC-26936
- BLU-782?
- EX-A3016
- AKOS037648893
- NCGC00846456-02
- AC-35823
- BS-15963
- HY-117887
- CS-0068415
- T8108
- D12711
- E74892
- Fidrisertib succinate
- UNII-WU1JNY62EH
- WU1JNY62EH
- D12712
- BLU-782 sesquisuccinate
- Fidrisertib succinate (USAN)
- Fidrisertib Succinate
- FIDRISERTIB SUCCINATE [USAN]
Look up FIDRISERTIB in the interactive SynDRA portal →